Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > This Board will change so much

<< Previous

Bullboard Posts

Next >>

Comment by Bangadaon Oct 21, 2021 10:26pm

101 Views

Post# 34035764

RE:This Board will change so much

Almost no hope left. Its all about the drug and trials, management is a total misfit. You are already dreaming, same dreams as 5 years ago...and 3 years....and last year. For your own health you should stop dreaming and only may start again when they accomplished one real milestone.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market